Dr. Benjamin A. Steinberg Named Chief Medical Officer at PaceMate

PaceMate has appointed nationally recognized cardiac electrophysiologist Benjamin A. Steinberg, M.D., as chief medical officer (CMO). An NIH-funded researcher and author of nearly 200 peer-reviewed publications, Dr. Steinberg possesses a combination of clinical depth, research rigor, and real-world expertise in applying artificial intelligence (AI) and data science to cardiac device management.

The appointment reflects PaceMate’s continued investment in its clinical leadership, executives claim. Built on a research-grade dataset aggregating discrete device, EHR, and operational data at scale, PaceMate is positioned to translate that data advantage into actionable clinical intelligence. As CMO, Dr. Steinberg will help shape PaceMate’s clinical direction, connecting its proprietary AI analytics engine to the clinical and scientific community and ensuring the platform remains aligned with the needs of device clinics, health systems, and patients.

“Dr. Steinberg sits at a rare intersection: a practicing electrophysiologist who also leads AI research at scale,” PaceMate CEO J.R. Finkelmeier stated. “His work has shaped how the field approaches personalized care for patients with implantable devices, and now that expertise lives inside PaceMate. We have a CMO who has lived the clinical and operational challenges our platform is built to solve. Dr. Steinberg is central to where PaceMate is headed.”

Dr. Steinberg is director of cardiac electrophysiology at Denver Health Medical Center and associate professor of Medicine at the University of Colorado Anschutz Medical Campus, where he treats patients and leads NIH-funded research for applying machine learning and AI to arrhythmia diagnosis and implantable device management. He earned his medical degree from Johns Hopkins University School of Medicine, completed residency on the Osler Service at The Johns Hopkins Hospital, and trained in cardiology and electrophysiology at Duke University. He is the principal investigator on multiple active NIH grants focused on personalized stroke risk stratification in atrial fibrillation and explainable AI for cardiac applications. Dr. Steinberg also holds leadership roles within the American College of Cardiology and Heart Rhythm Society, and serves on multiple editorial boards.

“PaceMate has built something genuinely different: a platform that understands how device clinics actually work, across millions of patients, with the data infrastructure to generate insights at a scale previously not possible,” Dr. Steinberg ssaid. “As a clinician and researcher, I have spent my career asking how we use data to personalize care and improve outcomes. PaceMate is the place where that question gets answered in practice. I am thrilled to join this team and help drive the next generation of clinical intelligence in remote cardiac monitoring.”

PaceMate serves integrated delivery networks and academic health systems nationwide with broad EHR integration capabilities and 14 vendor integrations covering every major device manufacturer. The platform delivers an average of 75% incremental revenue capture within six months and has reduced physician alert burden by 30%, driven by PaceMate’s proprietary alert analytics engine, built and owned in-house. With 18 peer-reviewed publications, PaceMate is among the few platforms in cardiac remote monitoring with a published clinical evidence base, according to the company. With Dr. Steinberg’s appointment, PaceMate strengthens its position as the cardiac remote monitoring platform where clinical science and technological innovation are built into the same infrastructure.

PaceMate is a tech-enabled cardiac device monitoring platform serving integrated delivery networks and academic health systems nationwide. EHR-agnostic and vendor-neutral, PaceMate unifies every major device manufacturer and EHR into one intelligent platform, giving clinical teams the workflow flexibility, population visibility, and patient-level intelligence to deliver care at scale. PaceMate manages more than 2.3 million patients and is backed by the industry’s only research-grade cardiac dataset built on discrete device, EHR, and operational data.